Concepedia

Hsin-Ju Hsieh

HH

3

Publications

554

Citations

3

H-Index

2011

Active since

Affiliations

Stanford University(Current)

Hsin-Ju Hsieh is an author at Stanford University specializing in medicine, dermatology, and pharmacotherapy.

Top concepts

Publications per year

2011–2016

3

Publications

3

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

Sarbjit S. Saini, Karin Rosén, Hsin-Ju Hsieh et al. · Journal of Allergy and Clinical Immunology · 2011 · 392 citations

, , +5

A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors

Lee S. Rosen, Patricia LoRusso, Wen Wee et al. · Investigational New Drugs · 2016 · 83 citations

, , +7

Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Ranjana H. Advani, Daniel Lebovic, Andy Chen et al. · Clinical Cancer Research · 2016 · 79 citations · Full text

Rows per page

1–3 of 3